PL2796550T3 - Nowe przeciwciało przeciwko ludzkiemu CTGF - Google Patents
Nowe przeciwciało przeciwko ludzkiemu CTGFInfo
- Publication number
- PL2796550T3 PL2796550T3 PL12860742T PL12860742T PL2796550T3 PL 2796550 T3 PL2796550 T3 PL 2796550T3 PL 12860742 T PL12860742 T PL 12860742T PL 12860742 T PL12860742 T PL 12860742T PL 2796550 T3 PL2796550 T3 PL 2796550T3
- Authority
- PL
- Poland
- Prior art keywords
- novel anti
- ctgf antibody
- human ctgf
- human
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011281811 | 2011-12-22 | ||
| EP12860742.1A EP2796550B1 (en) | 2011-12-22 | 2012-12-21 | Novel anti-human ctgf antibody |
| PCT/JP2012/083206 WO2013094723A1 (ja) | 2011-12-22 | 2012-12-21 | 新規抗ヒトｃｔｇｆ抗体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2796550T3 true PL2796550T3 (pl) | 2018-08-31 |
Family
ID=48668601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12860742T PL2796550T3 (pl) | 2011-12-22 | 2012-12-21 | Nowe przeciwciało przeciwko ludzkiemu CTGF |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9587015B2 (pl) |
| EP (1) | EP2796550B1 (pl) |
| JP (1) | JP6040943B2 (pl) |
| KR (1) | KR20140107507A (pl) |
| CN (1) | CN104011206B (pl) |
| AR (1) | AR089425A1 (pl) |
| BR (1) | BR112014015405A2 (pl) |
| CA (1) | CA2859627A1 (pl) |
| EA (1) | EA029290B1 (pl) |
| ES (1) | ES2665851T3 (pl) |
| IN (1) | IN2014CN04615A (pl) |
| MX (1) | MX345019B (pl) |
| PL (1) | PL2796550T3 (pl) |
| PT (1) | PT2796550T (pl) |
| TW (1) | TW201333034A (pl) |
| WO (1) | WO2013094723A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109824777A (zh) * | 2019-03-15 | 2019-05-31 | 辽宁何氏医学院 | 一种具有抑制玻璃体视网膜纤维化病变作用的单克隆抗体及其制备方法和应用 |
| US20200369759A1 (en) | 2019-05-23 | 2020-11-26 | Fibrogen, Inc. | Methods of treatment of muscular dystrophies |
| WO2020244540A1 (zh) * | 2019-06-04 | 2020-12-10 | 江苏恒瑞医药股份有限公司 | 抗结缔组织生长因子抗体及其应用 |
| CA3200705A1 (en) * | 2020-12-03 | 2022-06-09 | Xiazhen MA | Pharmaceutical composition comprising anti-connective tissue growth factor antibody |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8808645U1 (de) | 1988-07-06 | 1988-08-25 | Hofer, Daniel, 7730 Villingen-Schwenningen | Anzeigeeinrichtung für Feuerlöscher |
| ATE256751T1 (de) | 1993-03-11 | 2004-01-15 | Chemo Sero Therapeut Res Inst | Monoklonaler anti-hiv antikörper |
| EP1043335A4 (en) * | 1997-12-25 | 2005-08-31 | Japan Tobacco Inc | MONOCLONAL ANTIBODY AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND ITS MEDICAL APPLICATIONS |
| JP4537507B2 (ja) * | 1997-12-25 | 2010-09-01 | アムジェン インコーポレイテッド | 結合組織増殖因子に対するモノクローナル抗体及びその医薬用途 |
| US7115390B1 (en) | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
| DK1140969T3 (da) | 1998-12-14 | 2007-09-17 | Univ Miami | Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7405274B2 (en) | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
| JP2009067678A (ja) | 2005-12-07 | 2009-04-02 | Nihon Nosan Kogyo Kk | 結合組織増殖因子に対する抗体又はそれを含む組成物 |
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
-
2012
- 2012-12-21 AR ARP120104933A patent/AR089425A1/es unknown
- 2012-12-21 ES ES12860742.1T patent/ES2665851T3/es active Active
- 2012-12-21 IN IN4615CHN2014 patent/IN2014CN04615A/en unknown
- 2012-12-21 TW TW101148989A patent/TW201333034A/zh unknown
- 2012-12-21 US US14/367,081 patent/US9587015B2/en active Active
- 2012-12-21 EP EP12860742.1A patent/EP2796550B1/en active Active
- 2012-12-21 PL PL12860742T patent/PL2796550T3/pl unknown
- 2012-12-21 BR BR112014015405A patent/BR112014015405A2/pt unknown
- 2012-12-21 PT PT128607421T patent/PT2796550T/pt unknown
- 2012-12-21 JP JP2013550349A patent/JP6040943B2/ja not_active Expired - Fee Related
- 2012-12-21 EA EA201491240A patent/EA029290B1/ru not_active IP Right Cessation
- 2012-12-21 CA CA2859627A patent/CA2859627A1/en not_active Abandoned
- 2012-12-21 MX MX2014007681A patent/MX345019B/es active IP Right Grant
- 2012-12-21 CN CN201280063995.5A patent/CN104011206B/zh active Active
- 2012-12-21 KR KR1020147020039A patent/KR20140107507A/ko active IP Right Grant
- 2012-12-21 WO PCT/JP2012/083206 patent/WO2013094723A1/ja active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| MX345019B (es) | 2017-01-11 |
| MX2014007681A (es) | 2014-11-25 |
| CN104011206A (zh) | 2014-08-27 |
| EA029290B1 (ru) | 2018-03-30 |
| WO2013094723A1 (ja) | 2013-06-27 |
| EP2796550A4 (en) | 2015-08-19 |
| ES2665851T3 (es) | 2018-04-27 |
| EP2796550B1 (en) | 2018-02-28 |
| KR20140107507A (ko) | 2014-09-04 |
| IN2014CN04615A (pl) | 2015-09-18 |
| CN104011206B (zh) | 2017-03-08 |
| JPWO2013094723A1 (ja) | 2015-04-27 |
| EP2796550A1 (en) | 2014-10-29 |
| US20140343258A1 (en) | 2014-11-20 |
| US9587015B2 (en) | 2017-03-07 |
| TW201333034A (zh) | 2013-08-16 |
| AR089425A1 (es) | 2014-08-20 |
| EA201491240A1 (ru) | 2014-11-28 |
| BR112014015405A2 (pt) | 2017-06-13 |
| CA2859627A1 (en) | 2013-06-27 |
| PT2796550T (pt) | 2018-04-18 |
| JP6040943B2 (ja) | 2016-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180640T1 (hr) | Anti-b7-h3 antitijelo | |
| IL259826A (en) | Anti-alphabetatisiar antibody | |
| ZA201400768B (en) | Interleukin-31 monoclonal antibody | |
| EP2866833A4 (en) | CRYSTALLINE ANTIBODIES AGAINST HUMAN IL-23 | |
| GB201000064D0 (en) | Humanized antibodies | |
| ZA201400741B (en) | Novel anti-human ngf antibody | |
| HK1199038A1 (en) | Anti-human xcr1 antibodies xcr1 | |
| PL2695897T3 (pl) | Nowe przeciwciało przeciwko ludzkiemu receptorowi il-23 | |
| EP2796550A4 (en) | NEW ANTIBODY ANTI CTGF HUMAN | |
| PL2821416T3 (pl) | Nowe przeciwciało przeciwko ludzkiemu receptorowi IL-23 | |
| EP2769988A4 (en) | ANTI-GAP43 ANTIBODY | |
| HK1175486A1 (zh) | 抗腫瘤壞死因子α的人源化抗體 |